Schrodinger, Inc. (SDGR)
Schrodinger, Inc. (SDGR) from its SEC filings: 2025 revenue $255.9 million (+23% vs the year before), net margin -40%, free cash flow $12.5 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $255.9 million |
| Revenue growth | +23% |
| Net income | -$103.3 million |
| Net margin | -40.4% |
| Free cash flow | $12.5 million |
| Diluted EPS | $-1.41 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +8% |
| Cash | $287.9 million |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.